The cancer epigenome: Concepts, challenges, and therapeutic opportunities.
about
Transforming growth factor-β, matrix metalloproteinases, and urokinase-type plasminogen activator interaction in the cancer epithelial to mesenchymal transition.Epigenetic Regulation of Hepatitis B Virus Covalently Closed Circular DNA: Implications for Epigenetic Therapy against Chronic Hepatitis B.The histone variant H3.3 G34W substitution in giant cell tumor of the bone link chromatin and RNA processing.CR2Cancer: a database for chromatin regulators in human cancer.DiseaseEnhancer: a resource of human disease-associated enhancer catalog.Eosinophils: The unsung heroes in cancer?WD40 repeat domain proteins: a novel target class?Bivalent Epigenetic Control of Oncofetal Gene Expression in Cancer.Unravelling the biology of chromatin in health and cancer using proteomic approaches.The expression of hematopoietic progenitor cell antigen CD34 is regulated by DNA methylation in a site-dependent manner in gastrointestinal stromal tumours.SPOP tips the balance of BETs in cancer.Leptin-induced ER-α-positive breast cancer cell viability and migration is mediated by suppressing CCN5-signaling via activating JAK/AKT/STAT-pathway.Click chemistry enables preclinical evaluation of targeted epigenetic therapies.Encapsulating pH-Responsive Doxorubicin-Phthalocyanine Conjugates in Mesoporous Silica Nanoparticles for Combined Photodynamic Therapy and Controlled Chemotherapy.Double duty: ZMYND8 in the DNA damage response and cancer.Targeting EHMT2 reverses EGFR-TKI resistance in NSCLC by epigenetically regulating the PTEN/AKT signaling pathway.Chromatin reprogramming in breast cancer.Designer epigenome modifiers enable robust and sustained gene silencing in clinically relevant human cells.BET Family Protein BRD4: An Emerging Actor in NFκB Signaling in Inflammation and Cancer.Clinical laboratory and imaging evidence for effectiveness of agarose-agarose macrobeads containing stem-like cells derived from a mouse renal adenocarcinoma cell population (RMBs) in treatment-resistant, advanced metastatic colorectal cancer: EvaluIdentifying mislabeled and contaminated DNA methylation microarray data: an extended quality control toolset with examples from GEO.A network of epigenomic and transcriptional cooperation encompassing an epigenomic master regulator in cancer.
P2860
Q39443785-D1F1ED8B-ADB3-451A-AC41-910746359838Q40073818-4B87A364-4071-4ECD-9345-81BB60128C20Q42658896-693489A3-E439-4A23-A983-735ED56CECFFQ47160344-E83BB0A2-89FD-452F-852E-A685772CA6C5Q47167896-51631054-5E6F-4FF7-B0DD-4837B1A85227Q47225787-D39A2552-0CD7-4481-B8B1-2F21C337848BQ47291150-6DF940CB-91B3-4BD9-9B50-E636042DAE44Q47295917-B4E4C529-F406-4397-8C55-E45F23D3E5D4Q47818779-3778FB2B-5C10-4BA0-89FF-7F42D6CF902DQ48026867-117F8CD2-0AE0-4E43-AAC2-8B8BFB608913Q48102860-242AA3BF-4E71-4C1F-A903-C956015A93E6Q48261660-73CF3BE4-6809-4772-9584-D6E2388FC014Q48270517-A6E66412-0A1C-4535-BBD3-A19B7AE5B24CQ48297063-7989A7E2-8214-4285-AE42-90C11BF1B148Q49377046-1E42C5B8-1E46-46F9-853D-68168ADFEA38Q49646693-CEC82C04-E321-4D3F-BBD0-6063DFECDE32Q52310380-A224E711-577B-4B34-B0D5-C1B236539109Q52655847-6BC707A9-4650-44C5-8049-849B53C3E195Q52697946-5A75A608-3076-4883-908B-3ABB18A57780Q52726239-17DD1186-6C09-453E-9F8E-18516907243EQ55239795-FF82101C-7CB3-4E55-9D1A-CE97AB0A2F4CQ55516237-5F001ACF-90EE-435B-88F1-DF9F4034860A
P2860
The cancer epigenome: Concepts, challenges, and therapeutic opportunities.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
2017年论文
@zh
2017年论文
@zh-cn
name
The cancer epigenome: Concepts, challenges, and therapeutic opportunities.
@en
type
label
The cancer epigenome: Concepts, challenges, and therapeutic opportunities.
@en
prefLabel
The cancer epigenome: Concepts, challenges, and therapeutic opportunities.
@en
P2860
P356
P1433
P1476
The cancer epigenome: Concepts, challenges, and therapeutic opportunities.
@en
P2860
P304
P356
10.1126/SCIENCE.AAM7304
P407
P577
2017-03-16T00:00:00Z